| Details
|
| LDL |
Link Added : MHRA Drug Safety Update (Sep 2022): Methylphenidate long-acting (modified-release) preparations: caution if switching between products due to differences in formulations : https://www.gov.uk/drug-safety-update/methylphenidate-long-acting-modi
|
07/07/2023 15:48:51
(ebeavers )
|
| UPD |
sitematrix Changed from 0 to
|
30/06/2023 16:01:21
(dmcdermott )
|
| UPD |
FurtherInformation Changed from
- Methylphenidate is approved for use as a third line option (after e.g. antimuscarinics, imipramine, and pelvic floor exercises) in the treatment of giggle incontinence in children. Its use should be subject t
|
30/06/2023 16:01:21
(dmcdermott )
|
| UPD |
Methylphenidate tidy
|
30/06/2023 16:01:21
(dmcdermott )
|
| UPD |
sitematrix Changed from 0 to
|
03/11/2022 14:21:16
(LoweryM )
|
| UPD |
FurtherInformation Changed from
- Methylphenidate is approved for use as a third line option (after e.g. antimuscarinics, imipramine, and pelvic floor exercises) in the treatment of giggle incontinence in children. Its use should be subjec
|
03/11/2022 14:21:16
(LoweryM )
|
| UPD |
Methylphenidate formatting
|
03/11/2022 14:21:16
(LoweryM )
|
| UPD |
sitematrix Changed from 0 to
|
23/05/2022 10:32:17
(LoweryM )
|
| UPD |
FurtherInformation Changed from
- Methylphenidate is approved for use as a third line option (after e.g. antimuscarinics, imipramine, and pelvic floor exercises) in the treatment of giggle incontinence in children. Its use should be sub
|
23/05/2022 10:32:17
(LoweryM )
|
| UPD |
Methylphenidate UPDATED
|
23/05/2022 10:32:17
(LoweryM )
|
| UPD |
sitematrix Changed from 0 to
|
23/05/2022 10:31:05
(LoweryM )
|
| UPD |
FurtherInformation Changed from
- Methylphenidate is approved for use as a third line option (after e.g. antimuscarinics, imipramine, and pelvic floor exercises) in the treatment of giggle incontinence in children. Its use should be sub
|
23/05/2022 10:31:05
(LoweryM )
|
| UPD |
Methylphenidate UPDATED
|
23/05/2022 10:31:05
(LoweryM )
|
| UPD |
sitematrix Changed from 0 to
|
23/05/2022 10:29:58
(LoweryM )
|
| UPD |
FurtherInformation Changed from
- Methylphenidate is approved for use as a third line option (after e.g. antimuscarinics, imipramine, and pelvic floor exercises) in the treatment of giggle incontinence in children. Its us
|
23/05/2022 10:29:58
(LoweryM )
|
| UPD |
Methylphenidate UPDATED
|
23/05/2022 10:29:58
(LoweryM )
|
| UPD |
sitematrix Changed from 0 to
|
23/05/2022 10:29:16
(LoweryM )
|
| UPD |
FurtherInformation Changed from
- Methylphenidate is approved for use as a third line option (after e.g. antimuscarinics, imipramine, and pelvic floor exercises) in the treatment of giggle incontinence in children. Its use should be subjec
|
23/05/2022 10:29:16
(LoweryM )
|
| UPD |
Methylphenidate UPDATED
|
23/05/2022 10:29:16
(LoweryM )
|
| UPD |
Methylphenidate updated
|
30/10/2020 17:04:16
(DavidS )
|
| UPD |
Methylphenidate updated
|
30/10/2020 17:03:34
(DavidS )
|
| UPD |
Methylphenidate updted
|
30/10/2020 17:03:17
(DavidS )
|
| UPD |
Methylphenidate updated
|
22/09/2020 11:31:15
(DavidS )
|
| UPD |
Methylphenidate updated
|
22/09/2020 11:30:28
(DavidS )
|
| UPD |
Methylphenidate updated to remove third choice
|
22/09/2020 11:29:42
(DavidS )
|
| UPD |
Methylphenidate updated
|
20/08/2018 10:08:50
(DavidS )
|
| UPD |
Methylphenidate updated
|
20/08/2018 10:07:57
(DavidS )
|
| UPD |
Methylphenidate b
|
31/01/2017 16:34:39
(DavidS )
|
| UPD |
Methylphenidate b
|
20/01/2017 08:52:04
(WhitehallJ )
|
| UPD |
Methylphenidate b
|
20/01/2017 08:33:56
(WhitehallJ )
|
